Bristol-Myers Squibb has announced the first overall survival results from CheckMate -069, a Phase II trial evaluating the investigational combination of nivolumab and ipilimumab vs.
In a study appearing in JAMA, Antoni Ribas, M.D., Ph.D., of the University of California-Los Angeles, and colleagues examined tumor response and overall survival following administration of the...
New research highlights how vital it is to treat melanoma in an age-appropriate manner, suggesting anti-oxidants may be a more effective treatment for older patients.
In collaboration with researchers from UGent, VIB scientists from KU Leuven have revealed a remarkable link between malignant melanoma and a non-coding RNA gene called SAMMSON.
An HIV drug could stop one of the early changes in skin cancer cells that leads to them becoming resistant to treatment, according to a Cancer Research UK-funded study published in Cancer Cell.
Seeing builders stripped to the waist as they work on construction sites in the summer could be a thing of the past, thanks to a new project that will send personalised SMS warnings direct to their...
Biofrontera AG, the specialist for suninduced skin cancer, has announced the full results of its Phase III clinical trial evaluating BF-200 ALA for the treatment of basal cell carcinoma (BCC) that...
A blood test may be able to sound early warning bells that patients with advanced melanoma skin cancer are relapsing, according to a study published in the journal Cancer Discovery.
Most patients with melanoma had few moles and no atypical moles, and in patients younger than 60, thick melanomas were more commonly found in those with fewer moles but more atypical moles...